http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/?utm_source=rss&utm_medium=rss&utm_campaign=505b2-drug-approvals-rock Freshly Brewed Bio/Pharma Chat. Served Up Daily. Tue, 07 Feb 2012 11:57:58 +0000 hourly 1 http://wordpress.org/?v=3.3.1 http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/comment-page-1/#comment-53139 Sakuntala Tue, 03 Jun 2008 11:33:43 +0000 http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/#comment-53139 Can a generic player file both ANDA or 505(b)(2) application for the same drug product. How 30 months stay is effected, if we challenge the same patent for both ANDA and 505(b)(2) applications, . Will a generic player is subjected to multiple 30 months stay or single 30 month stay? Can a generic player file both ANDA or 505(b)(2) application for the same drug product. How 30 months stay is effected, if we challenge the same patent for both ANDA and 505(b)(2) applications, . Will a generic player is subjected to multiple 30 months stay or single 30 month stay?

]]> http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/comment-page-1/#comment-49119 Cornelius Diamond Wed, 23 Apr 2008 17:27:14 +0000 http://www.patentbaristas.com/archives/2008/04/22/505b2-drug-approvals-rock/#comment-49119 Does 505 b offer a path for biogenerics as well? Does 505 b offer a path for biogenerics as well?

]]>